Todos Medical Ltd.
TOMDFOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$14081
P/E Ratio—
52W High$0.00001
52W Low$0.000001
Todos Medical Ltd. (TOMDF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
TOMDF · earnings · updated Jun 9, 2026
Latest Earnings
Q4 FY2022Report Date: Nov 15, 2022EPS Actual
-$0.00
Revenue
$0.00B
Fiscal Period
Q4 FY2022
FY ends December
Report Date
Nov 15, 2022
After Market Close
TOMDF reports quarterly as a OTC-listed Medical - Diagnostics & Research company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q4 FY2022 | Nov 15, 2022 | — | -$0.00 | — | $0.00B | — | — |
| — Q2 FY2022 | Jun 30, 2022 | — | -$0.01 | — | $0.00B | — | — |
| — Q1 FY2022 | Mar 31, 2022 | — | -$0.01 | — | $0.00B | — | — |
| — Q4 FY2021 | Dec 31, 2021 | — | -$0.03 | — | $0.00B | — | — |
| — Q3 FY2021 | Sep 30, 2021 | — | -$0.01 | — | $0.00B | — | — |
| — Q2 FY2021 | Jun 30, 2021 | — | $0.01 | — | $0.00B | — | — |
| — Q2 FY2021 | Apr 21, 2021 | — | -$0.04 | — | $0.01B | — | — |
| — Q4 FY2020 | Dec 31, 2020 | — | -$0.01 | — | $0.00B | — | — |
Q4 FY2022
Nov 15, 2022
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2022
Jun 30, 2022
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2022
Mar 31, 2022
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2021
Dec 31, 2021
EPS Actual
-$0.03
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2021
Sep 30, 2021
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2021
Jun 30, 2021
EPS Actual
$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2021
Apr 21, 2021
EPS Actual
-$0.04
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q4 FY2020
Dec 31, 2020
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $1.54 | $1.54 | $1.54 | 1 |
| Q2 FY2024 | $1.34 | $1.34 | $1.34 | 1 |
| Q1 FY2024 | $1.58 | $1.58 | $1.58 | 1 |
| Q4 FY2023 | $2.09 | $2.09 | $2.09 | 1 |
| Q3 FY2023 | $1.39 | $1.39 | $1.39 | 1 |
| Q2 FY2023 | $1.19 | $1.19 | $1.19 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q4 FY2022 | Nov 15, 2022 | — | $0.01 | $0.01 | +1.69% |
| — Q2 FY2022 | Jun 30, 2022 | — | $0.01 | $0.01 | +0.75% |
| — Q1 FY2022 | Mar 31, 2022 | — | $0.02 | $0.02 | +2.86% |
| — Q4 FY2021 | Dec 31, 2021 | — | $0.05 | $0.06 | +6.42% |
| — Q3 FY2021 | Sep 30, 2021 | — | $0.04 | $0.04 | +5.82% |
| — Q2 FY2021 | Jun 30, 2021 | — | $0.03 | $0.03 | +6.15% |
| — Q2 FY2021 | Apr 21, 2021 | — | $0.05 | $0.05 | -6.40% |
| — Q4 FY2020 | Dec 31, 2020 | — | $0.07 | $0.08 | +3.45% |
Q4 FY2022+1.69%
Report Date
Nov 15, 2022
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q2 FY2022+0.75%
Report Date
Jun 30, 2022
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q1 FY2022+2.86%
Report Date
Mar 31, 2022
EPS Beat/Miss
—
Price Before
$0.02
Price After
$0.02
Q4 FY2021+6.42%
Report Date
Dec 31, 2021
EPS Beat/Miss
—
Price Before
$0.05
Price After
$0.06
Q3 FY2021+5.82%
Report Date
Sep 30, 2021
EPS Beat/Miss
—
Price Before
$0.04
Price After
$0.04
Q2 FY2021+6.15%
Report Date
Jun 30, 2021
EPS Beat/Miss
—
Price Before
$0.03
Price After
$0.03
Q2 FY2021-6.40%
Report Date
Apr 21, 2021
EPS Beat/Miss
—
Price Before
$0.05
Price After
$0.05
Q4 FY2020+3.45%
Report Date
Dec 31, 2020
EPS Beat/Miss
—
Price Before
$0.07
Price After
$0.08
Beat Rate0 / 8 quarters
Largest Move+6.42% (Q4 FY2021)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: TOMDF ends December
Todos Medical Ltd. (TOMDF) most recently reported earnings on November 15, 2022 for Q4 FY2022, posting EPS of $-0.00 (in line with the analyst consensus of —). The next TOMDF earnings date is expected around September 1, 2026.
Each quarter, investors track TOMDF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. TOMDF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
TOMDF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
TOMDF earnings · 4 questionsTodos Medical Ltd.'s next earnings report is expected around September 1, 2026. TOMDF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; TOMDF historically reports after market close (AMC).
TOMDF earnings datewhen is TOMDF earningsTOMDF next earnings datewhen does TOMDF report earningsTOMDF earnings calendar
▸ Source: FMP · Todos Medical Ltd. SEC filings · US GAAP · Todos Medical Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026